[Neurological aspects of multiple myeloma]. 1986

A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova

Neurological complications were examined in 30 patients with multiple myeloma. The neurological syndromes which play the key role in the clinical picture of the disease were distinguished. The pathogenetic mechanisms of the development of the individual symptoms and the methods for their treatment are discussed.

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
January 2005, Best practice & research. Clinical haematology,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
December 2019, Practical neurology,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
January 1967, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
January 1972, Archiv fur Geschwulstforschung,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
September 1977, Neurology India,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
October 1994, Soins; la revue de reference infirmiere,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
April 1956, Acta urologica Belgica,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
March 1954, Laval medical,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
October 1975, Medical times,
A K Golenkov, and L L Guseva, and A R Zlatkina, and T S Lagutina, and V I Markova
February 1959, Klinicheskaia meditsina,
Copied contents to your clipboard!